Join us to learn how to accelerate spatial biology discoveries by 70% with optimized, ready-to-go panels using SignalStar™ Multiplex IHC.
Many current spatial biology and multiplex immunohistochemistry technologies involve time-consuming methods for panel optimization, validation, and analysis—which typically take weeks to months, slowing down scientific discovery. With SignalStar Multiplex IHC, researchers can generate results in as little as two days with optimized, ready-to-go panels.
Join us for a webinar led by Dr. Sarah Klein, Associate Director of Multiplex Assay Development at Cell Signaling Technology, to learn about SignalStar Multiplex IHC, an innovative technology that empowers spatial biology research that harnesses the synergy of specific primary antibodies and a network of fluorescent oligonucleotides to efficiently amplify the signal of cellular proteins in formalin-fixed, paraffin-embedded (FFPE) tissue samples.
With SignalStar Multiplex IHC, you gain:
- Rapid Insights: Generate results in 2 days with optimized, ready-to-go panels
- Visual Clarity: Detect and visualize up to 8 targets in FFPE tissue
- Amplified Precision: Amplify the signal of targets with low levels of expression—no epitope loss or masking
- Instant Start: Leverage ready-to-go protocols that are validated and optimized to work out of the box
- Seamless Integration: Easily employ your existing fluorescent imagers
Key Topics Include:
- How SignalStar Multiplex IHC works—an overview of the mechanics and how it unlocks spatial insights
- How SignalStar Multiplex IHC demonstrates reproducibility and flexibility
- How to design experiments efficiently with a user-friendly online panel builder—enabling precision planning
Who Should Attend?
- Researchers using spatial biology technologies, especially multiplex immunohistochemistry
- Researchers running high-throughput analyses interested in efficient mid-plex immunohistochemistry assays
- Translational immuno-oncology researchers exploring the spatial context of tumor microenvironments
- Categories: Cancer & Oncology Research, Cell & Molecular Biology, Microbiology & Immunology, Microscopy
- Tags: fluorescence microscopy, formalin-fixed, immuno-oncology, immunohistochemistry (IHC), paraffin-embedded (FFPE) tissue, spatial biology, Tumor Microenvironment
Presenters
Sarah Klein, PhD
Associate Director
Multiplex Assays Group
Cell Signaling Technology
Sarah Klein, PhD, is the Associate Director of the Multiplex Assays Group at Cell Signaling Technology (CST). This group was instrumental in the development and validation of SignalStarTM Multiplex IHC. Dr. Klein has been with CST for 7 years, developing antibody-based solutions in the fields of immunology and oncology. She performed her postdoctoral research at Dana Farber Cancer Institute in Boston, MA, and her doctoral research at MD Anderson Cancer Center in Houston, TX, studying the mechanisms of action for immunotherapeutics used in the treatment of cancer, particularly glioblastomas.
Production Partner
Cell Signaling Technology Inc.
Cell Signaling Technology (CST) is a different kind of life sciences company—one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor for over 20 years. We consistently provide fellow scientists around the globe with best-in-class products and services to fuel their quests for discovery.
Additional Content From Cell Signaling Technology Inc.
Targeting Proteomics to Decipher Biology for the Drug Development Pipeline
Dr. Jeffrey Silva explores the role of mass spectrometry-based proteomics on drug discovery, disease mechanisms, and biomarker identification.
Additional Content From Scientist.com
Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment
In this webinar, Victor Arrieta highlights the link between p-ERK activation and improved survival in rGBM patients using anti-PD-1 immunotherapy.
Advancing Water Quality Monitoring: How to Easily Integrate Advanced Bioanalytical Techniques for Comprehensive Insights
Dr. Jack Vanden Heuvel discusses how integrating cell-based bioassays and effect-based trigger values enhances water quality assessment beyond traditional methods.
Impact of Sleep and Circadian Disruption on Human Health and Disease Risk
Join Josiane Broussard, PhD as she explains the links between sleep and circadian disruption and cardiovascular and metabolic health.
Related Content
Cut and Paste of Myosin Binding Protein-C in Striated Muscles
Dr. Samantha Harris discusses the development of three new mouse models in her lab, engineered to target and replace specific myosin binding protein-C paralogs in muscle fibers and impact of their mutations on skeletal and cardiac muscle diseases.
Revolutionizing Immunotherapy Research with 3D, Multiplexed Cryo-fluorescence Tomography
Dr. Matt Silva showcases the power of cryo-fluorescence tomography (CFT) in advancing immunotherapy research.
Past, Present, and Future of the Columbus Instruments “CLAMS”
In this virtual demo, Chris Adams introduces Columbus Instruments' Comprehensive Lab Animal Monitoring System (Oxymax-CLAMS).
